TABLE 1 Summary of Results of Antimicrobial Susceptibility Testing: Coxiella burnetii Using Chick Embryo or Guinea Pig Models |
|||||
Ref |
Author |
Model System |
Strain(s) Tested |
Antibiotic(s) Tested |
Results |
Huebner 1948 |
Chick embryos Guinea pigs |
Strains from patients with acute Q fever |
Streptomycin |
Reduced mortality |
|
Ormsbee 1951 |
Embryonated eggs |
Nine Mile |
Aureomycin Terramycin Chloramphenicol Streptomycin Pencillin G |
Most effective ↓ Least effective |
|
Ormsbee 1951 |
Chick embryos |
Nine Mile |
Terramycin Aureomycin Erythromycin Thiocymetin |
Effective Effective Ineffective Effective |
|
Keren 1994 |
Chick embryos |
Ohio 314 phase I |
Minocycline Ciprofloxacin Pefloxacin Fleroxacin |
Effective at 8 µg/g egg 1 µg/g egg 6 µg/g egg 1 µg/g egg |
TABLE 2 Summary of Results of Antimicrobial Susceptibility Testing: Coxiella burnetii Using Cell Culture Model |
|||||
Ref |
Author |
Cell Line |
Strain(s) Tested |
Antibiotics(s) Tested |
Results |
Keren 1994 |
Vero cells |
Ohio 314 |
Minocycline Fleroxacin Pefloxacin Ciprofloxacin |
95% growth inhibition at 2.5 mg/L
95% growth inhibition at 10 mg/L |
|
Torres 1993 |
HEL cells |
Nine Mile Q 212 Priscilla and 10 isolate from patients with chronic Q fever (Marseille) |
Ceftriaxone
Fusidic acid |
Inconclusive results Authors conclude these compounds could be effective |
|
Jabarit-Aldighieri 1992 |
L929 cells with addition of cycloheximide |
Q 212 Nine Mile 13 chronic fever Q isolates |
PD 127, 391} flouro-PD 131, 628} quinolones |
Both quinolones more active against Nine Mile strain than against Q212 (chronic Q fever strain), but neither drug could eliminate infection |
|
Raoult 1991 |
HEL cells |
Nine Mile Q212 Priscilla 10 chronic Q fever isolates |
Amoxicillin Amikacin Erythromycin Cotrimoxazole Pefloxacin Ciprofloxacin Chloramphenicol Tetracycline Doxycycline Minocycline Rifampin |
Nine Mile more susceptible than Q212 or Priscilla; all isolates were resistant to amoxicillin and amikacin; all were susceptible to rifampin, cotrimoxazole, and tetracyclines; heterogeneity of susceptibility to fluoroquinolones, chloramphenicol, and erythromycin |
|
Yeaman 1987 |
L929 |
Nine Mile |
Penicillin G |
Pencillin G, polymyxin B, |
|
Rolain 2000 |
HEL cells |
Nne Mile Q 212, Priscilla |
Telithromycin, erythromycin |
MIC for telithromycin 1 mcg/ml vs 8 mcg/ml for erythromycin. |
|
Yeaman 1987 |
|
|
Polymyxin B Sulfamethoxazole Trimethoprim Streptomycin Gentamicin Chloramphenicol Rifampin, novobiocin Nalidixic acid Oxolinic acid Ciprofloxacin Norfloxacin Ofloxacin |
sulfamethoxazole, trimethoprim, erythromycin, streptomycin, gentamicin-inactive, chloramphenicol, some activity; all others very active
|
|
|
Spiridacki
|
VERO cells |
130 isolates
|
Vibramycin, clarithromycin, ciprofloxacin |
Clarithromycin inhibited all isolates at4 mg/L, vibramycin 2 mg/L, ciprofloxacin 8 mg/L. |
|
Gikas et al |
|
9 isolates from Greek patients with acute Q fever |
Linezolid, pefoloxacin, Ciprofloxacin, trovafloxacin, doxycycline, clarithromycin |
MICs for linezolid and clarithromycin ranged from 2 to 4 mg/L.
|
TABLE 3 Antimicrobial Treatment of Various Manifestations of C. burnetii Infection [Download PDF] |
||
Condition |
Treatment1 |
Reference |
Acute Q fever Pneumonia
|
1. Doxycycline 100 mg b.i.d. p.o. for 10 days 2. Ciprofloxacin 500 mg b.i.d. p.o. for 10 days |
|
Chronic Q fever Endocarditis |
1. Doxycycline 100 mg b.i.d. p.o. plus hydroxychloroquine 200 mg t.i.d to achieve a chloroquine level of 1 mg/L 2. Ciprofloxacin 750 mg b.i.d. p.o. plus rifampin 300 mg o.d. p.o. 2 3. Doxycycline 100 mg b.i.d. p.o. plus rifampin 300 mg o.d. p.o.2 4. Doxycycline 100 mg b.i.d. p.o. plus a quinolone b
|
Author’s recommendations, |
Q fever in pregnancy |
1. Erythromycin 500 mg q. 6 h p.o. plus rifampin 300 mg o.d. p.o. for the duration of the pregnancy. After delivery, ciprofloxacin 500 mg b.i.d p.o. plus rifampin 300 mg o.d. p.o. for 6 months |
Author’s recommendation |
Q fever hepatitis |
Can occur as an acute or chronic form; treatment is as outlined for acute Q fever; chronic Q fever hepatitis-insufficient data to make any firm recommendations about duration of treatment; would use combination therapy as listed for endocarditis. Prednisone 0.5 mg/kg can be used in those who fail to defervesce. |
11, first choice; 2, choice, etc.
2All regimens to treat chronic Q fever must be given until IgA antiphase I antibody titer is < 1:200,
this usually requires at least 2 years.